多产子
发表于 2025-3-23 10:54:34
http://reply.papertrans.cn/83/8257/825677/825677_11.png
Inflammation
发表于 2025-3-23 17:40:55
http://reply.papertrans.cn/83/8257/825677/825677_12.png
贪心
发表于 2025-3-23 18:12:43
http://reply.papertrans.cn/83/8257/825677/825677_13.png
珊瑚
发表于 2025-3-24 00:14:03
http://reply.papertrans.cn/83/8257/825677/825677_14.png
prolate
发表于 2025-3-24 04:10:38
http://reply.papertrans.cn/83/8257/825677/825677_15.png
jabber
发表于 2025-3-24 09:10:55
Regulation of Genome Editing in Human iPS Cells: France,c cells for autologous retransplantation is likely to be considered an application of gene therapy medicinal products either regulated at the EU level as ATMPs in case of manufacturing at an industrial scale or at the French national level under national schemes if not manufactured at an industrial
入会
发表于 2025-3-24 11:48:36
Regulation of Genome Editing in Human iPS Cells: Switzerland,different forms of germ line interventions. As all such procedures require personal data, Swiss data protection requirements are analysed. Genetic data qualifies as sensitive data that calls for a higher level of protection. Despite the fact that several norms apply to questions of iPSCs and genome
fertilizer
发表于 2025-3-24 16:13:33
http://reply.papertrans.cn/83/8257/825677/825677_18.png
jocular
发表于 2025-3-24 23:05:24
http://reply.papertrans.cn/83/8257/825677/825677_19.png
精确
发表于 2025-3-25 02:33:29
Regulation of Genome Editing in Human iPS Cells: Republic of Korea,fe safety. In addition, the National Bioethics Committee which is directly responsible to the President decides on the guiding principles of bioethics and life safety policy. The new Advanced Regenerative Medicine Act provides for the establishment of a commission tasked with policy advice on advanc